Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of Biomarkers for the Assessment of Disease Activity of Eosinophilic Esophagitis (EoE) in Children
DRKS00014688Phase 4Not yet recruiting
- Sponsor
- Kinderklinik Erlangen
- Start
- Jul 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 2
01
Overview
Phase 4 trial of budesonide in eosinophilic esophagitis (EoE), gastroesophageal reflux disease (GERD) and Food hypersensitivity (4 arms), sponsored by Kinderklinik Erlangen. Primary endpoint: Biomarkers of eosinophilic esophagitis disease activity. Planned start Jul 2018; status: not yet recruiting.
02
Drugs
budesonide
03
Conditions
eosinophilic esophagitis (EoE)gastroesophageal reflux disease (GERD)Food hypersensitivity
Beyond the preview
Go deeper on DRKS00014688.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00014688.